Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Groundbreaking study to explore benefits of long-term pimecrolimus treatment

Dec. 1, 2004

Protalex pursues approval of PRTX-100 for pemphigus

Nov. 29, 2004

Non-approvable letter for Extina

Nov. 29, 2004

Cytochroma cleared to begin Canadian phase Ia study of CTA-018 for psoriasis

Nov. 25, 2004

SRP-299 discontinued for moderate to severe pediatric atopic dermatitis

Nov. 25, 2004

New formulations comprising epinastine

Nov. 25, 2004

Liarozole reported safe and effective in the treatment of ichthyosis and psoriasis

Nov. 24, 2004

Preclinical efficacy of rosiglitazone in reducing cutaneous inflammation in psoriasis

Nov. 23, 2004

IDEA-070 reduces inflammation and pain in UVB-induced sunburn

Nov. 22, 2004

A topical gel containing rAAT shows a good tolerability profile in patients with atopic dermatitis

Nov. 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...